1. Home
  2. CCCC vs PRE Comparison

CCCC vs PRE Comparison

Compare CCCC & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • PRE
  • Stock Information
  • Founded
  • CCCC 2015
  • PRE 2014
  • Country
  • CCCC United States
  • PRE Hong Kong
  • Employees
  • CCCC N/A
  • PRE N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • PRE Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CCCC Health Care
  • PRE Industrials
  • Exchange
  • CCCC Nasdaq
  • PRE Nasdaq
  • Market Cap
  • CCCC 115.0M
  • PRE 105.4M
  • IPO Year
  • CCCC 2020
  • PRE N/A
  • Fundamental
  • Price
  • CCCC $1.47
  • PRE $8.21
  • Analyst Decision
  • CCCC Buy
  • PRE Buy
  • Analyst Count
  • CCCC 3
  • PRE 1
  • Target Price
  • CCCC $12.00
  • PRE $9.00
  • AVG Volume (30 Days)
  • CCCC 943.9K
  • PRE 42.7K
  • Earning Date
  • CCCC 07-31-2025
  • PRE 06-17-2025
  • Dividend Yield
  • CCCC N/A
  • PRE N/A
  • EPS Growth
  • CCCC N/A
  • PRE N/A
  • EPS
  • CCCC N/A
  • PRE N/A
  • Revenue
  • CCCC $39,783,000.00
  • PRE $30,621,000.00
  • Revenue This Year
  • CCCC N/A
  • PRE $148.70
  • Revenue Next Year
  • CCCC N/A
  • PRE $82.89
  • P/E Ratio
  • CCCC N/A
  • PRE N/A
  • Revenue Growth
  • CCCC 98.56
  • PRE 40.83
  • 52 Week Low
  • CCCC $1.09
  • PRE $3.10
  • 52 Week High
  • CCCC $7.66
  • PRE $11.99
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 51.01
  • PRE 54.61
  • Support Level
  • CCCC $1.21
  • PRE $5.58
  • Resistance Level
  • CCCC $1.57
  • PRE $11.99
  • Average True Range (ATR)
  • CCCC 0.12
  • PRE 1.30
  • MACD
  • CCCC 0.02
  • PRE -0.13
  • Stochastic Oscillator
  • CCCC 70.27
  • PRE 41.03

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

Share on Social Networks: